Current State of the Art and Prospects of T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma

Current State of the Art and Prospects of T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma

Multiple myeloma (MM) patients eventually develop multi-drug-resistant disease with poor survival. Hence, the development of novel treatment strategies is of great importance. Recently, different classes of immunotherapeutic agents have shown great promise in heavily pre-treated MM, including T cell...

Full description

Bibliographic Details
Main Authors: Mashhour Hosny, Christie P. M. Verkleij, Jort van der Schans, Kristine A. Frerichs, Tuna Mutis, Sonja Zweegman, Niels W. C. J. van de Donk
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Journal of Clinical Medicine
Subjects:
bispecific antibody
multiple myeloma
BCMA
GPRC5D
CD38
FcRH5
Online Access:https://www.mdpi.com/2077-0383/10/19/4593

Internet

https://www.mdpi.com/2077-0383/10/19/4593

Similar Items